TECH vs VRTX: Which Stock is Better?
Side-by-side comparison of Bio-Techne Corp and Vertex Pharmaceuticals Inc in 2026
TECH
Bio-Techne Corp
$66.36
VRTX
Vertex Pharmaceuticals Inc
$454.67
Key Metrics Comparison
| Metric | TECH | VRTX | Winner |
|---|---|---|---|
| Market Cap | $10.37B | $118.09B | VRTX |
| P/E Ratio | 135.84 | 32.37 | VRTX |
| EPS (TTM) | $0.49 | $14.23 | VRTX |
| Revenue Growth | -0.0% | 0.1% | VRTX |
| Gross Margin | 66.8% | 52.7% | TECH |
Analyze TECH
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TECH or VRTX a better investment?
Comparing TECH and VRTX: Bio-Techne Corp has a market cap of $10.37B while Vertex Pharmaceuticals Inc has $118.09B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TECH and VRTX?
TECH (Bio-Techne Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TECH or VRTX?
Based on P/E ratios, VRTX trades at a lower multiple (32.4x vs 135.8x).
Which is growing faster: TECH or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.0% for TECH.
Which company is more profitable: TECH or VRTX?
Bio-Techne Corp (TECH) has higher gross margins at 66.8% compared to 52.7% for VRTX.
Which is the larger company: TECH or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $118.09B compared to $10.37B for TECH.
Should I buy TECH or VRTX in 2026?
Both TECH and VRTX have investment merit. TECH trades at $66.36 while VRTX trades at $454.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TECH and VRTX stock?
Key differences: Market Cap ($10.37B vs $118.09B), P/E Ratio (135.8x vs 32.4x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (66.8% vs 52.7%).